Rahway, NJ., January 29, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Commission (EC) has approved BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. The product […]
Rahway, NJ, January 24, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities […]
Winning veterinary student set to investigate canine distemper virus maternal antibody transfer in dogs Rahway, NJ, January 23, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the 2023 recipient of the World Small […]
The award marks the 6th year in a row for recognition in this category RAHWAY, N.J., Jan. 18, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced CIRCUMVENT® CML has been awarded the Best […]
More veterinary professionals are provided access to and are pursuing mental health resources for their overall wellbeing with continued improvements on the horizon RAHWAY, N.J., Jan. 15, 2024 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today […]
Rahway, NJ, December 11, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BRAVECTO® (fluralaner) 150 mg/ml powder and […]
First EU-licensed vaccine proven to protect against Cryptosporidium parvum in calves from birth onwards Rahway, N.J., Nov. 29, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has approved BOVILIS […]
Gilvetmab is Available to Veterinary Specialists Practicing Oncology to Treat Dogs with Mast Cell Tumors and Melanoma RAHWAY, N.J., Oct. 13, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that its caninized monoclonal […]
First cattle maternal vaccine effectively proven to protect against Cryptosporidium parvum in calves from birth onwards RAHWAY, N.J.,– Oct. 5, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Medicines Agency’s Committee […]
Company Reiterates a Commitment to Zero Dog-Mediated Human Rabies Deaths by 2030 RAHWAY, N.J., September 28, 2023 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today it has donated more than 5 million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. The goal […]